A randomized, open-label, single-dosing, crossover study to compare the safety and pharmacokinetic characteristics of TuNEX injection 25 mg with those of Enbrel injection 25 mg after subcutaneous injection in healthy male volunteers.

Trial Profile

A randomized, open-label, single-dosing, crossover study to compare the safety and pharmacokinetic characteristics of TuNEX injection 25 mg with those of Enbrel injection 25 mg after subcutaneous injection in healthy male volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Etanercept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 14 Nov 2011 Results published in the Clinical Therapeutics.
    • 26 Aug 2011 Actual initiation date (Mar 2007) added as reported by Korean Clinical Trials Register.
    • 26 Aug 2011 New source identified and integrated (Korean Clinical Trials Register; KCT0000118).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top